Parkinson’s Disease

7th October 2019

Therapeutic Approach to Neurodegenerative Diseases by Medical Gases: Focusing on Redox Signaling and Related Antioxidant Enzymes

Therapeutic Approach to Neurodegenerative Diseases by Medical Gases: Focusing on Redox Signaling and Related Antioxidant Enzymes   ABSTRACT   Oxidative stress in the central nervous system […]
7th October 2019

Oral ‘hydrogen water’ induces neuroprotective ghrelin secretion in mice

Oral ‘hydrogen water’ induces neuroprotective ghrelin secretion in mice   ABSTRACT   The therapeutic potential of molecular hydrogen (H₂) is emerging in a number of human […]
7th October 2019

Therapeutic Effects of Hydrogen in Animal Models of Parkinson’s Disease

Therapeutic Effects of Hydrogen in Animal Models of Parkinson’s Disease   ABSTRACT   Since the first description of Parkinson’s disease (PD) nearly two centuries ago, a […]
7th October 2019

Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydorxydopamine-induced Parkinson’s disease in rats

Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydorxydopamine-induced Parkinson’s disease in rats   ABSTRACT   BACKGROUND:  […]
7th October 2019

Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease

Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease   ABSTRACT   It has been shown that molecular hydrogen […]
4th October 2019

Pilot study of H2 therapy in Parkinson’s disease: A randomized double‐blind placebo‐controlled trial

Pilot study of H2 therapy in Parkinson’s disease: A randomized double‐blind placebo‐controlled trial   ABSTRACT   Background Oxidative stress is involved in the progression of Parkinson’s […]
4th October 2019

Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson’s disease

Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson’s disease   ABSTRACT   Molecular hydrogen serves as an antioxidant that reduces […]
4th October 2019

A review of hydrogen as a new medical therapy

A review of hydrogen as a new medical therapy   ABSTRACT   In the past few years many initial and subsequent clinical studies have demonstrated that […]
4th October 2019

Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals

Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals   ABSTRACT   Acute oxidative stress induced by ischemia-reperfusion or inflammation causes serious damage […]
Buy now